PEOPLE - PharmaNet (US) makes appointment:
This article was originally published in Clinica
PharmaNet (Princeton, New Jersey), a clinical development and consulting service for the pharmaceutical, medical device and biotechnology sector, has appointed Jeffrey McMullen as chief operating officer.
You may also be interested in...
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.
The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.